ImmunityBio (IBRX) Earnings Call Presentation

January 2025 ImmunityBio Investor Presentation Forward-Looking Statements and Intended Use This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding data and results from clinical trials and potential implications therefrom, commercialization plans and timelines, including product availability and shipments, potential regulatory pathways and approval requests and submissions, FDA, UK MHRA, EU EMA and other r ...